Assessment of inhibitory effect of letrozole on hepatic fibrosis

Assessment of inhibitory effect of letrozole on hepatic fibrosis - Assessment of inhibitory effect of letrozole on hepatic fibrosis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041649

Enrollment

400

Registered

2020-09-02

Start date

2020-08-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patients who were treated with letrozole and conducted blood tests of hepatic function

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Not applicable

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

Measure	Time frame
Age, sex, platelet count, AST, ALT, BMI level (weight, height), blood glucose level, HbA1c, blood albumin	—

Countries

Japan

Contacts

Public ContactKazuyoshi Okawa

Osaka International Cancer Institute Department of Hepatobiliary and Pancreatic Oncology

ohkawa-ka@mc.pref.osaka.jp06-6945-1181

Outcome results